These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30548972)

  • 1. Role of MDM2 309T>G (rs2279744) and I/D (rs3730485) polymorphisms and haplotypes in risk of papillary thyroid carcinoma, tumor stage, tumor size, and early onset of tumor: A case control study.
    Maruei-Milan R; Heidari Z; Salimi S
    J Cell Physiol; 2019 Aug; 234(8):12934-12940. PubMed ID: 30548972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Mouse Double Minute 2 -309T>G Polymorphism with Acute Myeloid Leukemia in an Iranian Population: A Case- Control Study.
    Soleymannejad M; Sheikhha MH; Neamatzadeh H
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):3037-3041. PubMed ID: 31653152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the MDM2 promoter polymorphism (-309T>G) in acute myeloid leukemia development.
    Cingeetham A; Vuree S; Jiwatani S; Kagita S; Dunna NR; Meka PB; Gorre M; Annamaneni S; Digumarti R; Sinha S; Satti V
    Asian Pac J Cancer Prev; 2015; 16(7):2707-12. PubMed ID: 25854351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
    Qiu M; Liu Y; Yu X; Qin L; Bei C; Zeng X; Qiu X; Tang B; He S; Yu H
    Tumour Biol; 2016 Mar; 37(3):3863-70. PubMed ID: 26476535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.
    Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S
    IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of CASP3 rs4647610 and rs4647602 polymorphisms on tumour size and cancer stage in papillary thyroid carcinoma.
    Heidari Z; Eskandari M; Aryan A; Rostamzad F; Salimi S
    Br J Biomed Sci; 2020 Jul; 77(3):129-134. PubMed ID: 32151194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of p53 and MDM2 genes are associated with severe toxicities in patients with non-small cell lung cancer.
    Zheng D; Chen Y; Gao C; Wei Y; Cao G; Lu N; Hou Y; Jiang X; Wang J
    Cancer Biol Ther; 2014; 15(11):1542-51. PubMed ID: 25482940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine double minute clone 2,309T/G and 285G/C promoter single nucleotide polymorphism as a risk factor for breast cancer: a Polish experience.
    Piotrowski P; Lianeri M; Rubis B; Knuła H; Rybczyńska M; Grodecka-Gazdecka S; Jagodziński PP
    Int J Biol Markers; 2012 Jul; 27(2):e105-10. PubMed ID: 22467100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of AXIN1 rs12921862 C/A and rs1805105 G/A and CTSB rs12898 G/A polymorphisms with papillary thyroid carcinoma: A case-control study.
    Saljooghi S; Heidari Z; Saravani M; Rezaei M; Salimi S
    J Clin Lab Anal; 2023 Jan; 37(1):e24804. PubMed ID: 36510340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma.
    Zhang F; Xu L; Wei Q; Song X; Sturgis EM; Li G
    Surgery; 2013 May; 153(5):711-7. PubMed ID: 23218882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.
    Bingül İ; Vural P; Doğru-Abbasoğlu S; Çil E; Uysal M
    J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 27925342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
    Wang ML; Xu YX; Qian J; Wang FH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma.
    Enokida Y; Shimizu K; Atsumi J; Kakegawa S; Takase Y; Kaira K; Yashima H; Araki T; Nakazawa S; Ohtaki Y; Nagashima T; Alexander L; Usui K; Ishikawa T; Hayashizaki Y; Takeyoshi I
    Cancer Med; 2016 Aug; 5(8):1791-801. PubMed ID: 27228500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Genetic Polymorphisms in microRNA Machinery Genes and Risk of Papillary Thyroid Carcinoma.
    Mohammadpour-Gharehbagh A; Heidari Z; Eskandari M; Aryan A; Salimi S
    Pathol Oncol Res; 2020 Apr; 26(2):1235-1241. PubMed ID: 31250375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of MDM2-309 polymorphisms and induced corresponding plasma MDM2 levels in susceptibility to laryngeal squamous cell carcinoma.
    Zhou J; Liu F; Zhang D; Chen B; Li Q; Zhou L; Lu LM; Tao L
    DNA Cell Biol; 2014 Feb; 33(2):88-94. PubMed ID: 24325471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
    Dong G; Zhang R; Xu J; Guo Y
    Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 T309G has a synergistic effect with P21 ser31arg single nucleotide polymorphisms on the risk of acute myeloid leukemia.
    Ebid GT; Sedhom IA; El-Gammal MM; Moneer MM
    Asian Pac J Cancer Prev; 2012; 13(9):4315-20. PubMed ID: 23167335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDM2 309T>G polymorphism and risk of lung cancer in a Korean population.
    Park SH; Choi JE; Kim EJ; Jang JS; Han HS; Lee WK; Kang YM; Park JY
    Lung Cancer; 2006 Oct; 54(1):19-24. PubMed ID: 16876289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of the genetic polymorphisms of antioxidant enzymes on susceptibility to papillary thyroid carcinoma.
    Salimi S; Harati-Sadegh M; Eskandari M; Heidari Z
    IUBMB Life; 2020 May; 72(5):1045-1053. PubMed ID: 32031754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
    Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
    Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.